4 hrs ago | Pharmaceutical Processing
Johnson & Johnson Completes Cougar Biotech Deal
Johnson & Johnson said Friday it completed its $893.7 million acquisition of Cougar Biotechnology Inc., a development stage company that is testing a potential vaccine for prostate cancer.
12 hrs ago | Med Ad News
Vertex Pharmaceuticals Announces Intention to Sell Its Rights to...
Jul 10, 2009 - Vertex Pharmaceuticals Incorporated today announced its intention to sell the rights to certain milestone payments tied to the future regulatory filing, approval and market launch of its hepatitis C virus protease inhibitor drug candidate, telaprevir, in Europe.
Oil hovers near $60 as traders eye company results
Oil prices hovered just above $60 a barrel Friday in Asia as investors braced for a slew of company earnings reports next week that will provide clues on the strength of crude demand.
Sotheby's London Evening Sales of Old Master Paintings Totals $60 Million
Tonight in London before a lively saleroom, Sothebya TMs sales of Old Master Paintings and Renaissance & Baroque Masterworks from the Collection of Barbara Piasecka Johnson brought a combined total of A 36,022,625/ $57,917,177/ a 41,645,761 , a strong figure comfortably within the pre-sale expectations for the evening of A 29,222,500-42,470.000.
Myths about Warren Buffett, Berkshire Hathaway
MCD , KO , MSFT , LLY , PFE , JNJ MCD , KO , MSFT , LLY , PFE , JNJ Warren Buffett is the richest investor in the world.
David Greising: 'Comparative effectiveness' is common sense
The $1.7 billion verdict against Abbott Laboratories last week is the latest evidence that the drug industry needs to heal itself by steering away from the me-too rut where resources, time and health are wasting away.
Elan Does Right by Its Shareholders
CEO Kelly Martin deserves praise for shepherding last week's deal with Johnson & Johnson that puts the Irish drugmaker on firmer financial footing.
Vistakon Names Dave Brown President for Americas
The Vistakon division of Johnson & Johnson Vision Care today named Dave Brown president, Vistakon Americas, responsible for Vistakon's U.S. and Canadian businesses.
Wandsworth woman had been 'planning suicide for some time'
A a oeseemingly happy and successfula Wandsworth woman committed suicide after taking a cocktail of prescription drugs, an inquest heard on Tuesday.
"Brave" post-Lehman M&A rewarded by market -study
Stock markets rewarded companies such as Johnson & Johnson and Cisco who were brave enough to make acquisitions in the months after Lehman Brothers' collapse, a study released on Monday showed.
Tylenol Dose Should Be Cut to Reduce Liver Risk, U.S. Advisory Panel Says
Johnson & Johnson a s 50-year-old painkiller Tylenol should have lower doses to prevent liver injury, a U.S. panel said.
Biotech Firm Becton Dickinson a Safe Bet
While politicians debate the future of the nationa s health-care system, one fund manager says there is no debating the growth potential of large-cap, medical technology firm Becton, Dickinson and Company .
Cougar Biotechnology Announces Successful Completion of Johnson &...
Cougar Biotechnology, Inc. announced today that the initial offering period of Johnson & Johnson's tender offer for all the outstanding shares of Cougar common stock expired at midnight on July 2, 2009.
Centocor v. Abbott: Biggest Patent Verdict Ever.
From a post by Joe Mullin: Centocor v. Abbott: Biggest Patent Verdict Ever. : This afternoon, a jury in Marshall, Texas, awarded the largest patent verdict in history: Abbott Laboratories must pay $1.67 billion to Centocor, a subsidiary of Johnson & Johnson, because its Humira arthritis treatment infringes U.S. Patent No.
Stocks in the Spotlight Thursday
American depositary receipts of the Irish biotech surged 8.6% on news that it agreed to sell its Alzheimer's immunotherapy program assets to Johnson & Johnson for a $1 billion investment.
Video: Axel Ullrich Named Winner of 2009 Dr. Paul Janssen Award for Biomedical Research
Paul Janssen Award for Biomedical Research. An independent committee of world-renowned scientists selected Dr.
Johnson & Johnson pays $1B for Elan stake
Johnson & Johnson will take an 18.4 percent stake in Ireland-based drug developer Elan Corp.
FDA panel backs cut in maximum Tylenol dosage
It is one of the world's most popular drugs, considered safe to treat fevers in children and aches and pains in pregnant women.
Abbott Ordered To Pay $1.7B Patent Claim
The U.S. District Court in Marshall, Texas, ordered Abbott Laboratories to pay Johnson & Johnson $1.7 billion in patent-related damages.
FDA Scientists Warn About Bleeding Risk of Bayer's Blood-Thinning Drug
The FDA has publicly released documents from science reviewers expressing concern over the blood-thinning drug rivaroxaban, marketed by Bayer AG and Johnson & Johnson as Xarelto in Canada and Europe.